Murderous!

The Hubei proprietary Chinese medicine procurement plan with volume is not gentle.

Yesterday, the Hubei Inter-provincial Procurement Alliance for Procurement of Chinese Patent Medicines issued a centralized procurement announcement.

After reading the relevant interpretation, many friends who have been engaged in market access for nearly 15-20 years with Hubei proprietary Chinese medicines are very emotional: they all say that they cannot be superstitious now, which seems to be right

Back to the main text

This time, there are two grouping units of Hubei Chinese patent medicine AB.

Since the announcement has been issued, the author focuses only on how to be shortlisted in detail

Hubei's finalists basically continue to use the double-envelope strategy but have upgraded on the basis of the double-envelope

It can be seen from the above figure that the applying company declares the price according to the representative product of the quoted price, and determines the price competition score through the decrease of the declared price

After the companies are shortlisted, according to the proposed selection rules, the price reductions of all A competition units of the 17 product groups are ranked from high to low, and the top 70% of the companies (rounded to the nearest integer, the same below) are directly eligible for the proposed selection.

A company’s access friend, Xiao Gang (pseudonym), communicated with the author yesterday: The document clarified that at least three companies in Group A have at least three in two, and the top three with the largest share will inevitably be eliminated before looking at the overall decline in Group A 70 %, I feel everyone is turning a blind eye

An industry analyst who did not want to be named told the author yesterday that the Hubei plan cannot be lenient at all! Collecting the quantity is the battle of life and death, only once! Look at the wailing of those companies that have failed the bid and the pharmaceutical companies that have not caught up with the state's centralized procurement

The same situation, group B differ

After so many years, the author suddenly discovered that the most uncontrollable bargaining of the year has now become the most controllable

Of course, Hubei is also worried that if there are too few selected companies, it still keeps a hand, that is, adding the proposed companies

Let me add another digression, Hubei’s leaded procurement of proprietary Chinese medicines is of obvious state-designated nature, that is, entrusting Hubei to carry out special procurement of proprietary Chinese medicines.